great stock ...but it takes time , page-3

I agree totally.

My take is that 3M's products that are/might be earmarked for the emPatch are pharmaceutical/drug applications rather than "cosmetic" applications. It seems right now that the interested parties are both looking at OBJ's patch for the latter. 3M are jumping into bed with OBJ as they will get the spin off of getting to manufacture the patch for these other interested parties if/when they strike a deal with OBJ. Then as research progresses by themselves and they are happy that they can use the patch with some of their drugs they can then make their "move" subsequently manufacturing for themselves and others in another sector of the market where i believe they currently have little or no exposure... just my thoughts and opinions...

IMO the story has just started... its not over!!

SMilez..